CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at Royal Bank of Canada from $102.00 to $91.00. They now have an "outperform" rating on the stock.
CVS Health Corporation (CVS)
Last cvs health corporation earnings: 2/12 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.cvshealth.com
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
CVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CVS alerts
High impacting CVS Health Corporation news events
Weekly update
A roundup of the hottest topics
CVS
News
- CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at Mizuho from $86.00 to $72.00. They now have a "buy" rating on the stock.MarketBeat
- CVS Health Co. (NYSE: CVS) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $60.00 price target on the stock, down previously from $85.00.MarketBeat
- UPDATE 1-Cigna sees strong annual profit on lower costs, pharmacy benefit strength [Yahoo! Finance]Yahoo! Finance
- Cigna sees strong annual profit on lower costs, pharmacy benefit strength [Yahoo! Finance Canada]Yahoo! Finance Canada
- Cigna sees strong annual profit on lower costs, pharmacy benefit strength [Yahoo! Finance]Yahoo! Finance
CVS
Earnings
- 5/1/24 - Miss
CVS
Sec Filings
- 5/1/24 - Form 10-Q
- 5/1/24 - Form 8-K
- 4/16/24 - Form PX14A6G
- CVS's page on the SEC website